Cargando…
Hypouricemia and Urate Transporters
Hypouricemia is recognized as a rare disorder, defined as a serum uric acid level of 2.0 mg/dL or less. Hypouricemia is divided into an overexcretion type and an underproduction type. The former typical disease is xanthinuria, and the latter is renal hypouricemia (RHUC). The frequency of nephrogenic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945357/ https://www.ncbi.nlm.nih.gov/pubmed/35327453 http://dx.doi.org/10.3390/biomedicines10030652 |
_version_ | 1784673939465699328 |
---|---|
author | Otani, Naoyuki Ouchi, Motoshi Misawa, Kazuharu Hisatome, Ichiro Anzai, Naohiko |
author_facet | Otani, Naoyuki Ouchi, Motoshi Misawa, Kazuharu Hisatome, Ichiro Anzai, Naohiko |
author_sort | Otani, Naoyuki |
collection | PubMed |
description | Hypouricemia is recognized as a rare disorder, defined as a serum uric acid level of 2.0 mg/dL or less. Hypouricemia is divided into an overexcretion type and an underproduction type. The former typical disease is xanthinuria, and the latter is renal hypouricemia (RHUC). The frequency of nephrogenic hypouricemia due to a deficiency of URAT1 is high in Japan, accounting for most asymptomatic and persistent cases of hypouricemia. RHUC results in a high risk of exercise-induced acute kidney injury and urolithiasis. It is vital to promote research on RHUC, as this will lead not only to the elucidation of its pathophysiology but also to the development of new treatments for gout and hyperuricemia. |
format | Online Article Text |
id | pubmed-8945357 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89453572022-03-25 Hypouricemia and Urate Transporters Otani, Naoyuki Ouchi, Motoshi Misawa, Kazuharu Hisatome, Ichiro Anzai, Naohiko Biomedicines Review Hypouricemia is recognized as a rare disorder, defined as a serum uric acid level of 2.0 mg/dL or less. Hypouricemia is divided into an overexcretion type and an underproduction type. The former typical disease is xanthinuria, and the latter is renal hypouricemia (RHUC). The frequency of nephrogenic hypouricemia due to a deficiency of URAT1 is high in Japan, accounting for most asymptomatic and persistent cases of hypouricemia. RHUC results in a high risk of exercise-induced acute kidney injury and urolithiasis. It is vital to promote research on RHUC, as this will lead not only to the elucidation of its pathophysiology but also to the development of new treatments for gout and hyperuricemia. MDPI 2022-03-11 /pmc/articles/PMC8945357/ /pubmed/35327453 http://dx.doi.org/10.3390/biomedicines10030652 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Otani, Naoyuki Ouchi, Motoshi Misawa, Kazuharu Hisatome, Ichiro Anzai, Naohiko Hypouricemia and Urate Transporters |
title | Hypouricemia and Urate Transporters |
title_full | Hypouricemia and Urate Transporters |
title_fullStr | Hypouricemia and Urate Transporters |
title_full_unstemmed | Hypouricemia and Urate Transporters |
title_short | Hypouricemia and Urate Transporters |
title_sort | hypouricemia and urate transporters |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945357/ https://www.ncbi.nlm.nih.gov/pubmed/35327453 http://dx.doi.org/10.3390/biomedicines10030652 |
work_keys_str_mv | AT otaninaoyuki hypouricemiaanduratetransporters AT ouchimotoshi hypouricemiaanduratetransporters AT misawakazuharu hypouricemiaanduratetransporters AT hisatomeichiro hypouricemiaanduratetransporters AT anzainaohiko hypouricemiaanduratetransporters |